United States

North China Pharmaceutical Co Ltd (600812.SS)

600812.SS on Shanghai Stock Exchange

25 Jul 2016
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for 600812.SS


North China Pharmaceutical Company. Ltd is a China-based company principally engaged in the production and distribution of pharmaceuticals. The Company's main products are classified as penicillin, cephalosporin, vitamin and other products, including bulk pharmaceuticals, finish preparations and healthcare products, among... (more)
No analyst recommendations are available for 600812.SS.


Beta: 1.21
Market Cap(Mil.): ¥10,991.62
Shares Outstanding(Mil.): 1,630.81
Dividend: 0.02
Yield (%): 0.30


  600812.SS Industry Sector
P/E (TTM): 185.67 36.15 37.05
EPS (TTM): 0.04 -- --
ROI: 0.67 15.11 14.35
ROE: 1.13 16.17 15.56

BRIEF-North China Pharmaceutical unit gets GMP certificate

* Says it unit receives goods manufacture practice (GMP) certificate from Hebei Food and Drug Administration

Jul 05 2016

BRIEF-North China Pharmaceutical unit gets WHO PQ authentication

* Says its unit gets WHO PQ(Confirmation of WHO Active Pharmaceutical Ingredient Pre-qualification) authentication for its streptomycin sulfate

Jun 28 2016

BRIEF-North China Pharmaceutical to pay 2015 dividend on June 21

* Says it will pay cash dividend of 0.02 yuan per share (before tax) for 2015 to shareholders of A shares of record on June 20

Jun 15 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
Provider : Reuters Investment Profile
Provider : Wright Reports
Provider : GlobalData
Provider : Thomson Reuters Stock Report

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.